$3.13
00.00%
Pre-Market: Sep 20, 4:29 PM EDT
15 minutes delayed
Aprea Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Aprea Therapeutics using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-12 | $-0.58 | $-0.64 | 9.38 % |
Mar 2024 | 2024-05-14 | $-0.67 | $-0.78 | 14.1 % |
Dec 2023 | 2024-03-26 | $-0.92 | $-0.77 | -19.5 % |
Sep 2023 | 2023-11-09 | $-0.86 | $-1.16 | 25.9 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-12 | $561.57K | $50.00K | 1023.2 % |
Dec 2023 | 2024-03-26 | $14.08K | $110.00K | -87.2 % |
Sep 2023 | 2023-11-09 | $319.47K | $80.00K | 299.3 % |
Aprea Therapeutics (APRE) is scheduled to report earnings on November 7, 2024. The last reported earnings were for reported on August 12, 2024 for Q2.
The Actual EPS was $-0.58, which beat the estimate of $-0.64.
The Actual Revenue was $561.6K, which beat the estimate of $50K.
Browse earnings estimates, EPS, and revenue on all stocks.